QCLS Q4 2017 Earnings Massive EPS Miss Fails to Deter Investors UHT Q1 2026 Earnings Solid EPS Growth Amidst Stable Portfolio Performance Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress NVS Q1 2026 Earnings EPS Misses Estimates Yet Shares Edge Higher BGMS Q3 2024 Earnings Significant EPS Beat Tempered by Revenue Uncertainty APRE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 215